Picture of Vericel logo

VCEL — Vericel News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Vericel Corp expected to post a loss of 8 cents a share - Earnings Preview

* Vericel Corp  VCEL.OQ   VCEL.O  is expected to show a rise in
quarterly revenue when it reports results on August 4. 
* The Cambridge, Massachusetts-based company is expected to
report   a 83.2% increase in revenue to $36.667 million from
$20.01 million a year ago, according to the mean estimate from 8
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Vericel Corp is for a
loss of 8 cents per share. For the same quarter last year, the
company reported a loss of 18 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Vericel Corp is
$66​, about 19.8% above​ its last closing price of $52.94. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.04       -0.04      -0.07     Missed  -66.2
 Dec. 31 2020  0.20        0.20       0.25      Beat    23.5
 Sep. 30 2020  -0.07       -0.06      0.08      Beat    223.9​
 Jun. 30 2020  -0.18       -0.21      -0.18     Beat    12.9
 Mar.          -0.08​      -0.08      -0.10     Missed  -22.4​
 31​ 2020​                                              
 Dec. 31 2019  0.20        0.20       0.20      Met     1.7​
 Sep. 30 2019  -0.04       -0.02      0.07      Beat    519.9
 Jun. 30 2019  -0.46       -0.46      -0.05     Beat    89.2
 This summary was machine generated August 2 at 12:45 GMT.  All
figures in US dollars unless otherwise stated

Recent news on Vericel

See all news